Similarly, in juvenile dermatomyositis, GDF-15 levels strongly correlate with disease activity scores and functional measures, making it a valuable biomarker for evaluating disease activity and guiding treatment decisions [66]. This evidence concerns the gene GDF15 and juvenile dermatomyositis.